COVID-19’s Demands on Pharma

In this ISSUE

Is ICER’s Speed Coming at the Expense of Credibility?

COVID-19 Highlights Need for More Agility, New Paradigms in Drug Development

COVID-19 and Pharma’s In-Person Sales Model

COVID-19

COVID-19: Repurposing Existing Therapeutics

Janita Good looks at some of the therapeutics currently under investigation and the issues they have highlighted in the context of a pandemic
… /Read more/

COVID-19

How Medical Affairs Teams Need to Adapt

COVID-19 will cause acute strain on medical affairs in the short term, but longer-term planning is also needed to ensure that teams can remain in the more visible role that customers are demanding, writes Sarah Jarvis
… /Click here to listen/

COVID-19 Highlights Need for More Agility, New Paradigms in Drug Development
The rapid spread of COVID-19 across the globe highlights the absolute need for preparedness in the face of pandemics in order to reduce and eliminate the emergence of new cases and quickly create treatment options for emerging illnesses and diseases. As it stands now, the sluggish response to the current crisis combined with the slow, rigid development process for therapies have been extremely inefficient and ineffective at handling the current crisis, thus signaling the need for faster, more agile paradigms.
Read the Article

COVID-19

Leading Teams through the Pandemic Crisis

Suzanne Bates offers advice for leaders who are steering their teams through the current health crisis
… /Read more/

MARKETING

Design Thinking in Multichannel Marketing

While marketers must work with less than perfect insight when devising their channel strategies, they can improve their success rate by applying Design Thinking
… /Read more/

Audio

The Pharm Exec Podcast: Cannabinoids

Yuval Cohen, CEO of Corbus Pharmaceuticals, talks about cannabinoids, the differences between natural and synthetic products, and how biotechs and pharma are using them to treat disease today
… /Click here to listen/

COVID-19

Notice to Pharm Exec Subscribers

Due to COVID-19, we will be delivering each issue to you via email. Please note issues will also still be delivered to you via postal mail and will be awaiting your return to the office. If you wish to change your delivery address, or delivery preference, you can do so via our online subscription form here: http://mmhpubs.mmhgroup.com/?pubid=PHEX&promocode=PHEXCOVID

Calendar

/ June 2: PING Conference 2020 /

Hatfield, UK

/ June 14–18, 2020: DIA 2020 Global Annual Meeting /

Washington, D.C.

/ June 15–17: BePharma 2020 /

Mexico City, Mexico

/ June 16–17: Financial Strategies and Accounting /

San Francisco, CA

/ June 16–18: Patient Support Services Congress /

Philadelphia, PA

/ June 23¬–25: 16th Annual Commercial Contract & Chargeback Excellence /

Philadelphia, PA

/ August 11–13: 14th Annual Forum on Transparency & Aggregate Spend /

Washington, D.C.

/ September 22–23, 2020: MedDevice MedTech Congress /

Boston, MA

Industry update

//AstraZeneca appointed Tom Keith-Roach as President of its UK business. Keith-Roach joins the AZ UK team following a number of in-country, above-country and global therapy area leadership positions. //Crescendo Biologics (Cambridge, UK) appointed Kenji Hashimoto as Chief Medical Officer. //Genmab (Copenhagen, Denmark) appointed Anthony Mancini as Executive Vice President and to the newly created position of Chief Operating Officer. //Galecto (Copenhagen, Denmark), a clinical stage company developing treatments for fibrosis and cancer, appointed Bertil Lindmark as Chief Medical Officer.

Patient Experience Breakthroughs: Leveraging the Latest Digital Tools and Techniques to Optimize your Patient Experience Goals
Tuesday, May 19, 2020 at 1pm EDT | 12pm CDT | 10am PDT
Register now

advertise with us / print subscribe / digital subscribe / visit pharmexec.com